Executive Director, Statistical Programming
- Employer
- 4D Molecular Therapeutics
- Location
- Remote, United States
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Information Technology, Bioinformatics
- Required Education
- Bachelors Degree
- Position Type
- Full time
By clicking apply, your email address will be shared with the employer.
Job Details
Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.
4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery
GENERAL SUMMARY:
The Executive Director of Statistical Programming will provide strategic and operational leadership for statistical programming across assigned development programs. The role will apply deep programming expertise to guide in-house deliverables, ensure rigorous quality review of outsourced statistical deliverables, and establish scalable standards and processes. They will serve as a senior member of cross-functional teams, partnering with Biostatistics, Data Management, Clinical Development, Regulatory, Clinical Operations, Quality, IT, and external vendors to plan, prioritize, and execute activities supporting program and organizational objectives.
MAJOR DUTIES & RESPONSIBILITIES:
Provide strategic and operational statistical programming leadership for assigned indications and development programs that may consist of multiple clinical trials and submission deliverables
Partner closely with biostatisticians and cross-functional stakeholders to review statistical analysis plans and ensure development of clear, fit-for-purpose data and analysis programming specifications
Ensure complete, auditable, and inspection-ready programming documentation for clinical trial analyses and regulatory submissions
Lead the development, governance, documentation, and maintenance of reusable programming code, standards, templates, and best practices
Partner with IT and functional leadership to define and maintain fit-for-purpose statistical computing infrastructure, including the SAS server environment and related tools
Provide senior statistical programming expertise and, as needed, biometrics leadership on select projects and cross-functional initiatives
Collaborate with various functions to ensure robust CRF/EDC development, and quality data collection for the assigned clinical trials
Oversee biometrics vendors and external programming partners to ensure timely, high-quality statistical deliverables, effective issue escalation, and clear accountability
Ensure quality review of outsourced statistical deliverables, including in-house double programming or quality control as needed, and coordinate internal review comments and resolution
Lead or contribute to the development of function-level standards, SOPs, work instructions, templates, and continuous improvement initiatives
Stay abreast of industry developments in biostatistics, statistical programming, regulatory expectations, automation, and data standards, and apply relevant advancements to systems and processes
Establish programming strategy, resource priorities, quality expectations, and risk mitigation plans, and communicate key decisions and escalations to senior stakeholders
Other duties as assigned, nothing in this job description restricts management’s right to assign or reassign duties and responsibilities to this job at any time.
QUALIFICATIONS:
Education:
A./B.S. degree in statistics, computer science, or other quantitative science major required
Advanced degree (M.A./M.S.) preferred, or equivalent experience
Experience:
17+ years of relevant statistical programming, biometrics, or clinical development experience, including significant leadership experience in clinical development and regulatory submissions
Demonstrated experience leading statistical programming strategy and execution for regulatory submissions, including BLA/IND or equivalent global health authority submissions
8+ years of management experience, including scale-up of in-house programming team
Experience in ophthalmology and/or biologic/gene therapy a plus
Other Qualifications/Skills:
Expert SAS programming skills required, with proficiency in SAS/BASE, SAS Macros, SAS/STAT, and ODS; proficiency in SAS/SQL, SAS/GRAPH, or SAS/ACCESS is a plus
Proficiency in R programming a plus
Proficiency in Microsoft Office Apps, such as WORD, EXCEL, and PowerPoint (familiar with the “Chart” features in EXCEL/PowerPoint a plus)
Strong understanding of standards specific to clinical trials, including CDISC, SDTM, ADaM, CDASH, MedDRA, and WHODrug
Experience with all clinical phases (I, II, III, and IV) is desirable
Experience leading or overseeing BLA/IND submissions is strongly desirable
Good understanding of regulatory requirements for submission-related activities (e.g., CDISC, CDASH, eCTD) and CRT packages (e.g., XPTs Define/xml, reviewer’s guide, analysis metadata report, executable programs) is desirable
Able to run the P21 checks is a plus
Knowledge of applicable GCP/FDACHMP//ICH/HIPPA regulations
Displays excellent organization, prioritization, and time management skills, with strong attention to detail and the ability to lead multiple complex priorities in a fast-paced environment with shifting timelines and competing demands
Excellent written and verbal communication skills, with the ability to influence senior stakeholders and communicate complex technical information clearly across functions
Proven conceptual, analytical, strategic, and enterprise-level thinking
Strong interpersonal, vendor oversight, people leadership, and project management skills
Proactively identifies risks, issues, and possible solutions, and drives timely decision-making, escalation, and resolution
Travel: <5%
Physical Requirements and Working Conditions:
Physical Activity - Repetitive motions: Making substantial movements (motions) of the wrists, hands, and/or fingers. Fingering: Picking, pinching, typing or otherwise working, primarily with fingers rather than with whole hand or arm as in handling. Talking: Expressing or exchanging ideas by means of the spoken word.
Physical Requirements - Sedentary work: Exerting up to 10 pounds of force occasionally and/or a negligible amount of force frequently or constantly to lift, carry, push, pull or otherwise move objects, including the human body. Sedentary work involves sitting most of the time. Jobs are sedentary if walking and standing are required only occasionally and all other sedentary criteria are met.
Working Conditions - The worker is not substantially exposed to adverse environmental conditions (as in typical office or administrative work).
Base salary compensation range: $298,000 - $340,000
Please note, the base salary compensation range and actual salary offered to the final candidate depends on various factors: candidate’s geographical location, relevant work experience, skills, and years of experience.
4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.
Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities
Company
4DMT is a gene therapy company with a transformative discovery platform --Therapeutic Vector Evolution --that enables our “disease first” approach to product discovery and development, thereby allowing us to customize our AAV vectors to target specific tissue types associated with the underlying disease.
At 4DMT we are creating and developing optimized “biopharmaceutical grade” AAV vectors that will allow us uniquely to unlock the full potential of gene therapy. Our customized and proprietary AAV vectors are each designed, according to a 4DMT Target Vector Profile, to deliver genes to specific cells and tissues in the body to eradicate both rare and large market diseases.
While AAV gene therapy pioneers are making great strides with the first wave of products, hurdles still exist with the use of conventional vectors. The most commonly used AAV capsids (e.g., AAV2, 5, 8 and 9) were identified either 1) as contaminants in lab stocks of adenovirus, or 2) through monkey tissue processing. Therefore, these conventional vectors are not targeted specifically to any tissue in the body. This can lead to inefficient and non-specific delivery, thus requiring extremely high doses and potentially resulting in toxicities (including inflammation), high manufacturing burdens and suboptimal efficacy. In addition, suboptimal routes of delivery can be required for delivery to the right tissues (e.g., subretinal delivery to the retina). Finally, pre-existing neutralizing antibodies in many patients can limit efficacy, clinical trial enrollment and market sizes. 4DMT Innovation empowers us to create new and improved next generation AAV capsids to allow targeted delivery of our products by the optimal clinical route of administration.
At 4DMT we use our robust discovery platform, termed “Therapeutic Vector Evolution,” to create customized and proprietary gene delivery vehicles (novel AAV vectors) to deliver genes to specific tissues and cells in the body by the optimal route of administration. We use the power of evolution to create and refine these optimized vectors through genetic diversification and then natural selection in vivo.
4D Purpose Statement: Boldly Innovating to Unlock the Full Potential of Gene Therapy for Countless Patients
GUIDING PRINCIPLES
Dare to Cure - Patients are waiting. Create big dreams for patients and take calculated risks to achieve them
Break Boundaries - Question the status quo and innovate beyond conventional approaches
Beyond Yourself - It's about patients, their families, our team, our families. We strengthen each other.
Prepare and Execute Relentlessly - Start with the end in mind, over-prepare and make contingency plans to your contingency plans
We invite all of you who share our passion and vision in creating the ultimate gene therapy products to cure genetic and rare diseases in children and adults. We seek the best people in the industry who identify with our mission and innovative results-driven approach. We offer an inspiring and collaborative environment that encourages individual contributions, recognizes performance in multiple ways, offers generous benefits and provides challenging opportunities for career development.
- Phone
- 510-505-2680
- Location
- 5858 Horton St. Suite 455
Emeryville
California
94608